- Home
- TRUG vs ALZN Comparison
TRUG vs ALZN Comparison
Compare TRUG & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUG
- ALZN
- Stock Information
- Founded
- TRUG 1983
- ALZN 2016
- Country
- TRUG United States
- ALZN United States
- Employees
- TRUG N/A
- ALZN N/A
- Industry
- TRUG
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- TRUG
- ALZN Health Care
- Exchange
- TRUG NYSE
- ALZN Nasdaq
- Market Cap
- TRUG 6.4M
- ALZN 7.0M
- IPO Year
- TRUG N/A
- ALZN 2021
- Fundamental
- Price
- TRUG $0.48
- ALZN $1.33
- Analyst Decision
- TRUG
- ALZN Strong Buy
- Analyst Count
- TRUG 0
- ALZN 1
- Target Price
- TRUG N/A
- ALZN $35.00
- AVG Volume (30 Days)
- TRUG 360.0K
- ALZN 123.2K
- Earning Date
- TRUG 11-29-2024
- ALZN 12-13-2024
- Dividend Yield
- TRUG N/A
- ALZN N/A
- EPS Growth
- TRUG N/A
- ALZN N/A
- EPS
- TRUG N/A
- ALZN N/A
- Revenue
- TRUG $21,917,131.00
- ALZN N/A
- Revenue This Year
- TRUG N/A
- ALZN N/A
- Revenue Next Year
- TRUG N/A
- ALZN N/A
- P/E Ratio
- TRUG N/A
- ALZN N/A
- Revenue Growth
- TRUG N/A
- ALZN N/A
- 52 Week Low
- TRUG $0.35
- ALZN $1.31
- 52 Week High
- TRUG $11.82
- ALZN $19.20
- Technical
- Relative Strength Index (RSI)
- TRUG 32.62
- ALZN 34.37
- Support Level
- TRUG $0.35
- ALZN $1.31
- Resistance Level
- TRUG $0.58
- ALZN $1.47
- Average True Range (ATR)
- TRUG 0.09
- ALZN 0.10
- MACD
- TRUG 0.00
- ALZN -0.01
- Stochastic Oscillator
- TRUG 39.21
- ALZN 18.47
About TRUG TRUGOLF HOLDINGS INC
TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games ("Links"), innovative hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.